In The Press
Whether it’s Peter’s view on the Apple Watch or coverage of our events you’ll find the latest stories, comments and conversations here.
Rebuilding meaningful healthcare provider relationships
In a recent article for PharmaTimes, our Head of Strategy Stu Whyte and Head of CX Veronica Naguib share their insight on why (and how) pharmaceutical brands can evolve their value proposition and rebuild meaningful relationships with HCPs and patients.
The BIO Agency is 1st for creativity
Econsultancy’s 2018 Top 100 Digital Agencies Report reveals BIO’s strong position across a number of categories.
Peter Veash named The Most Influential Person in the industry
Our CEO Peter has been named the Most Influential Person in the industry in Econsultancy’s 2018 Top 100 Digital Agencies report. In this recent interview for Econsultancy, he shares what distinguishes BIO’s approach and how BIO’s way of working stacks up against the competition.
Connected cars accelerate the need for OEMs to go omnichannel
Our CEO Peter Veash discusses why traditional showrooms are no longer fit for purpose, the value of personalisation and smart manufacturing, and why the post-purchase relationship matters.
Customer experience makes the difference – whether B2C or B2B
Stu Whyte – our Head of Strategy – explores the story behind Amazon's success across the B2C and B2B sectors.
Why it's time for telcos to differentiate
In a recent article for Telecoms Tech News, our CSO discussed the need for telcos to focus on customer experience and adapt their services to survive and meet growing customer demands.
Awareness doesn’t equal behaviour change
In this newest article for PharmaTimes, our CX Consultant Max Crichton explores how patient-led digital solutions can solve some of the major pharma industry problems.